Source: ERS Live 2007
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. F. Rabe (Leiden, The Netherlands). COPD treatment from pathophysiology to clinical trials. ERS Live 2007

Member's Comments

No comment yet.

Related content which might interest you: The clinical diagnosis and treatment of COPD Source: International Congress 2019 – An update on chronic obstructive pulmonary disease Year: 2019 A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019 Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials Source: International Congress 2017 – COPD management Year: 2017 The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Clinical and functional effectiveness of roflumilast in severe COPD patients Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients Source: Eur Respir J, 58 (6) 2101702; 10.1183/13993003.01702-2021 Year: 2021 The role of phonophoresis in patients with COPD: a randomized clinical trial Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Heterogeneity of treatment response in bronchiectasis clinical trials Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 How to increase the value of randomised trials in COPD research Source: Eur Respir J 2009; 34: 552 Year: 2009 Measuring bronchodilation in COPD clinical trials Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs) Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013